Companies Biotech and healthCoverage 3 of 5Updated Oct 1, 2026

Astrocyte Pharmaceuticals

Private. Astrocyte Pharmaceuticals is developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders

Last round: $9.5M Series B
Backed by: DeepWork Capital
Launched: 2014
People: 6

Overview

Updated Oct 1, 2026

Every fact carries a numbered source. Where we can't source something, it says so.

Identity fields from the company record are sourced where a source is recorded; those have no number.

Headquarters: Groton, CT¹
Website: astrocytepharma.com opens in a new tab⁴
Sector: Biotech and health · as of 2026-09-30⁵
Stage: Series B · as of 2026-09-30⁵
Total raised: $40 million · as of 2026-09-30⁵
Founded: 2014 · as of 2024-09-08²
Geography: Groton, CT

Funding

How much has Astrocyte Pharmaceuticals raised?

Rounds and backers, each sourced.

Rounds

2026-09-30
Series B · $9.5M raised⁵
Led by DeepWork Capital

Who backs Astrocyte Pharmaceuticals?

DeepWork CapitalLed the Series B, 2026-09-30⁵

Opportunities For accredited investors

Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.

For accredited investors

Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.

No live opportunities right now. Accredited investors are notified first when one opens.

Create an accredited profile

A vehicle is never smaller than $1,000,000.

People

Who founded and leads Astrocyte Pharmaceuticals?

Names and titles only, each sourced.

Russell B. Poe, Ph.D.Head of Chemistry and Manufacturing Controls (CMC)³
Theodore E. Liston, Ph.D.Vice-President of Research³
William S. Korinek, Ph.D.Co-Founder and Chief Executive Officer³
Stanley A. Roberts, Ph.D., D.A.B.T.Head of Non-Clinical Safety Assessment³
Lisa Manna, RN, MBAVice-President of Clinical Development Operations³
James D. Lechleiter, Ph.D.Co-Founder and Advisor³

Sources

Every claim on this page traces to one of these. The numbers match the citations above.

1
Contact - Astrocyte Pharmaceuticals opens in a new tabHeadquarters · accessed Oct 1, 2026
2
Senator Chris Murphy Highlights Groton's Astrocyte Pharmaceuticals As "Innovator Of The Month" opens in a new tabFounded · accessed Oct 1, 2026
3
Team - Astrocyte Pharmaceuticals opens in a new tabPeople · accessed Oct 1, 2026
4
Astrocyte Pharmaceuticals Inc. opens in a new tabWebsite · accessed Oct 1, 2026
5
Astrocyte Pharmaceuticals Secures $9.5 Million Series B to Advance Phase 2 Clinical Development of Breakthrough TBI and Concussion Therapy AST-004 opens in a new tabSector, Stage, Total raised, Funding · accessed Oct 1, 2026

Something wrong or missing? Sign in to report it, or claim this company if you work here.